DIAGNOS Announces Private Placement
BROSSARD, QUEBEC -- (Marketwire) -- 01/17/13 -- DIAGNOS inc.
("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the
use of artificial intelligence and advanced knowledge extraction
techniques, announces that it has arranged a non-brokered private
placement consisting of up to 14,000,000 units ("Units") to be issued
at $0.10 per Unit, for gross proceeds of $1,400,000.
The proceeds of the private placement will be mainly used to fund
business development of the healthcare services and to fund product
development with regards to the healthcare line of business.
Each Unit is comprised of one Common Share and one Common Share
purchase warrant ("Warrant"). Each Warrant entitles its holder to
acquire one Common Share at a price of $0.15 at any time during the
18 months following the closing date, scheduled for February 7, 2013.
At least one insider of the Corporation is expected to participate
for greater than 25% of the private placement.
Finder's fees may be payable in whole or part on the private
placement in accordance with the policies of the TSX Venture
The Units will be sold in Canada on a prospectus-exempt basis. All
monies quoted in this press release shall be stated and paid in
lawful money of Canada.
This proposed private placement is subject to receipt of all required
regulatory approvals, including that of the TSX Venture Exchange, as
well as the negotiation and execution of formal documentation.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation,
with a mission to commercialize technologies combining contextual
imaging and traditional data mining thereby improving decision making
processes. DIAGNOS offers products, services, and solutions to
clients in a variety of fields including healthcare, natural
resources, and entertainment.
For further information, please visit our website at www.diagnos.com
or the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Service Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
1-877-678-8882 or (450) 678-8882, ext.: 224
Bid Capital Markets
Press spacebar to pause and continue. Press esc to stop.